BEIRUT

Health

US implant device helps prevent clotting: study

This undated image provided by Boston Scientific on Wednesday, Feb. 27, 2013 shows an experimental heart device called the Watchman. (AP Photo/Boston Scientific)

WASHINGTON:An implant device designed by US firm Boston Scientific to prevent strokes in high risk people helps avert blood clotting, a new study said.

The umbrella-shaped device called "Watchman" can also serve as an alternative to treatment with anticoagulants of patients suffering from arterial fibrillation, a study by the manufacturer said.

The trials involved 407 patients at 41 sites and compared the "Watchman" to warfarin, an anticoagulant medication, said the study, which was presented on Saturday.

Of the people surveyed, 269 used "Watchman" and 138 took the blood thinner warfarin.

The results show that "the device performed similar to warfarin with a rate ratio of 1.07", said the report, presented at an annual conference of the American College of Cardiology.

"The results ... add to the wealth of previously published data confirming the utility of the 'Watchmen' device as an option for the reduction of stroke in high risk patients," said Kenneth Stein, chief medical officer with the cardiac rhythm management department of Boston Scientific.

"'Watchman' is the only device-based alternative to anticoagulation that has undergone rigorous scientific study," he added.

"Watchman" is introduced into the heart via a catheter that goes through a vein in the groin.

Atrial fibrillation affects approximately 15 million patients worldwide. A Patients have a five times greater risk of stroke.

"Watchman" was approved for sale in Europe in 2005 and some countries in Asia in 2009, according to Boston Scientific.

The results of the study will be submitted to the US Food and Drug Administration as part of a process to obtain approval for its marketing in the United States.

 

Recommended

Advertisement

Comments

Your feedback is important to us!

We invite all our readers to share with us their views and comments about this article.

Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.

Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)

comments powered by Disqus

Advertisement

FOLLOW THIS ARTICLE

Interested in knowing more about this story?

Click here